Our findings also encompassed the “ERBB2 signaling pathway”, with this BC driver gene being responsible for coding HER2, a transmembrane glycoprotein that belongs to the epidermal growth factor receptor (EGFR) family [74]. This evidence concerns the gene ERBB2 and breast cancer.